Excited to release my lab's first preprint! A foundational model for clone & epistasis-aware biomarkers. This approach addresses key challenges in understanding genetic interactions & clonal dynamics.
Looking forward to feedback & new collaborations! biorxiv.org/content/10.1101/…
PCF Young Investigator Awards recognize early career scientists poised to lead the future of prostate cancer research.
Andrea Miyahira, Ph.D., PCF VP of Global Research & Innovation, shares how these awards help accelerate promising research careers.
As we close out #WomensHistoryMonth, we honor the women of PCF whose leadership is helping shape the future of prostate cancer. Their voices, and women’s voices everywhere, spark conversations that lead to early detection and save lives. 💙
If you or a loved one has prostate cancer, germline genetic and somatic testing can open doors—to better treatment options, clinical trials, and a clearer picture of your family's cancer risk.
Medical oncologist Dr. @EHeath4100 walks you through: bit.ly/47wv4Qt#MedEd
FUO 2026 applications are open! Senior urology residents (PGY3 in Aug 2026) are invited to join the inaugural SUO Future Urologic Oncologists program in Indianapolis (July 24–26) for mentorship, education, and networking with leaders in urologic oncology. Apply by April 20!
Thrilled to share the latest from @gungulati and team in collab with #MattFreedman. #LiquidBiopsy can reveal gene expression in cancer by integrating circulating histone mods and cfDNA fragmentation patterns. Excited to see how this expands the reach of precision oncology!
We infer earthquakes from distant vibrations and stars from photons emitted light-years away.
Can we reconstruct a patient’s tumor biology from the signals it sheds into blood?
Introducing APEX (Associating Plasma Epigenomics with eXpression), our framework for inferring cancer expression from plasma.
Preprint: biorxiv.org/content/10.64898…@biorxivpreprint@DanaFarber@DrChoueiri@SylvanBacaLab#FreedmanLab
RFA for SUO Fellows & YUO Members!
Apply by March 1, 2026 for up to $25,000 to develop innovative, patient-centered clinical trial concepts in urologic oncology.
Funding & mentorship from SUO leaders.
Apply here: bit.ly/46NmtII
Many thanks to @UroToday for highlighting our study published in @NatureCancer! ♥️Truly appreciate the 10-year unwavering supports from @PCFnews for launching my career in #Prostate Cancer research! 🌹
This #Thanksgiving, we are incredibly grateful for the incredible team that makes our mission possible: our dedicated employees, researchers, leadership and supporters who believe in our purpose.
We wish you and your loved ones a season filled with gratitude and joy.
The 32nd Annual #PCFRetreat25 brought together the brightest minds in #ProstateCancer research to discuss groundbreaking science, collaboration and innovation. Here's to continued breakthroughs in research ahead.
#Research#Innovation#ThinkTank
The 32nd Annual #PCFRetreat25 brought together the brightest minds in #ProstateCancer research to discuss groundbreaking science, collaboration and innovation. Here's to continued breakthroughs in research ahead.
#Research#Innovation#ThinkTank
"The energy, the science, the medicine. It's so rich." @soulehoward1, PhD, EVP & Chief Science Officer recaps the 32nd Annual PCF Scientific Retreat. #PCFRetreat25
See you all at the @PCF_Science AnnualRetreat!
Stop by our poster: "Machine Learning based Detection of Concurrent DNA Repair Deficiencies as Dynamic Biomarkers for Prostate Cancer Precision Medicine"
Discuss approach, hear your thoughts! Collab #ProstateCancer#PrecisionMedicine